Uterine septum surgery may boost IVF success in infertile women

NCT ID NCT07611656

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether a surgery called transcervical resection of the septum (TCRS) can improve pregnancy outcomes for infertile women with a uterine septum who are planning IVF. The trial will compare live birth rates between women who get the surgery and those who don't. About 236 participants aged 20-40 will be followed for 12 months after treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
hysteroscopic transcervical resection of the septum (TCRS) surgery
What this could lead to
If successful, this could show that removing a uterine septum improves live birth rates for infertile women undergoing IVF, offering a clear surgical option.
What could go wrong
This is a relatively small, early-stage trial. Surgery carries risks like infection or uterine damage, and the benefit over no surgery may be small or absent.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFERTILITY AND MISCARRIAGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The Third Xiangya Hospital of Central South University

    RECRUITING

    Changsha, Hunan, 410013, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.